Because CDH1 mRNA is markedly upregulated in the early stages of tumor development of some types of tumors, such as colon and endometrial carcinomas, CDH1 mRNA levels may serve as a reliable biomarker for the early diagnosis of these carcinomas. This evidence concerns the gene CDH1 and endometrial carcinoma.